|
Product Detail :
|
AUTOLOGUS CYTOKINE RICH SERUM TUBING SET .
* SRPHC425563-AUTOLOGUS CYTOKINE RICH SERUM TUBING SET 1) THE DEVICE SHOULD BE CO
MPLETELY AUTOLOGOUS. 2) PATIENTS OWN BLOOD SHOULD BE USED AND THERE SHOULD NO EXTERNAL AD
DITION TO THE PATIENT SAMPLE COLLECTED. 3) THE FINAL DERIVATIVE TO BE INJECTED SHOULD SERUM-PLA
SMA WITHOUT FIBRINOGEN. 4) THE DEVICE SHOULD HAVE GLASS BEADS TO PRODUCE ANTI-INFLAMMATORY
CYTOKINES PRIMARILY IL1RA. 5) THE PROCESS OF SERUM PREPARATION SHOULD INVOLVES INCUBATION UPT
O 3 HOURS AT 37 DEGREE CENTIGRADE. 6) THE BLOOD SAMPLE SHOULD BE CENTRIFUGED AT 4000 RPM FOR
FIVE MINUTES POST INCUBATION PERIOD. 7) THE PLATELETS TO BE ACTIVATED INSIDE THE DEVICE AND NOT
EXTERNALLY. 8) 3-5 ML OF SERUM SHOULD BE OBTAINED FROM 10ML VENOUS BLOOD COLLECTED. 9) THE FI
NAL SERUM IS RICH IN ANTI-INFLAMMATORY IL1RA AND ACTIVATED GROWTH FACTORS. THE KIT SHOULD BE S
UPPLIED WITH ALL REQUIRED EQUIPMENT FOR THE PROCESS. TECHNICALLY COMPETENT PERSON FOR PROCE
SSING SHOULD BE SENT AS AND WHEN REQUIRED BASIS. UNITNO ]
|
| Tender Detail : |
AUTOLOGUS CYTOKINE RICH SERUM TUBING SET |